Aftab Mathur

Aftab Mathur

Active Director Nominee Director DIN 06594968
DIN 06594968 First appointment Jun 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 2 historical roles
Total affiliations 4 Since Jun 2013
Shareholding value •••• Premium profile

About Aftab Mathur

Data last updated:

Aftab Mathur is a Nominee Director at Sterling Biotech Limited (since 2025) and Director at Evolutionx Debt Capital Advisors India Private Limited (since 2023). The companies operate in Pharma, Business Services and Financial Services. The largest current company by reported revenue is Sterling Biotech Limited at ₹767 Cr (FY 2025). Earlier, Aftab Mathur was a Director at Innoven Capital India Private Limited (2015–2021) and Director at Videonetics Technology Private Limited (2013–2014).

DIN 06594968
Primary Designation Nominee Director
Industry Pharma
First Appointment 04 Jun 2013
Oldest Company Age 41 yrs
Largest company Sterling Biotech Limited · ₹767 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sterling Biotech Limited L51900MH1985PLC035738
Nominee Director25 Jun 20251985₹767 Cr (FY 2025)Active
Director28 Jun 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Apr 20152007₹24,000 (FY 2024)Active
Director04 Jun 20132008₹78.84 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Aftab Mathur

NameDINCompanyDesignation
Alok Kumar Garg10630493Sterling Biotech LimitedNominee Director
Anil Shantilal InaniSterling Biotech LimitedCfo
Keyur Anilkumar Parekh08868570Sterling Biotech LimitedNominee Director
Monisha Prabhu Macedo00144660Sterling Biotech LimitedNominee Director
Neha Champaben PrajapatiSterling Biotech LimitedCompany Secretary
Priyadarshan Kumar Singh11606849Sterling Biotech LimitedAdditional Director
Vishal Jyotindra Gor08787850Sterling Biotech LimitedNominee Director
Rahul Jitendra Shah06555196Evolutionx Debt Capital Advisors India Private LimitedDirector
Ranjit Sinha Amit10218491Evolutionx Debt Capital Advisors India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sterling Biotech Limited
Evolutionx Debt Capital Advisors India Private Limited
Innoven Capital India Private Limited
Videonetics Technology Private Limited
Premium access

Shareholding and investment profile for Aftab Mathur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aftab Mathur

Aftab Mathur currently holds 2 directorships: Sterling Biotech Limited (Nominee Director, since 25 Jun 2025, revenue ₹767 Cr (FY 2025)); Evolutionx Debt Capital Advisors India Private Limited (Director, since 28 Jun 2023).

Aftab Mathur was first appointed on 04 Jun 2013 as Director at Videonetics Technology Private Limited. The most recent appointment on record is 25 Jun 2025 at Sterling Biotech Limited.

Aftab Mathur held 2 earlier board appointments: Innoven Capital India Private Limited (Director, 13 Apr 2015 to 03 May 2021); Videonetics Technology Private Limited (Director, 04 Jun 2013 to 22 May 2014).

The current boards of Aftab Mathur's companies include Alok Kumar Garg (Sterling Biotech Limited), Anil Shantilal Inani (Sterling Biotech Limited), Keyur Anilkumar Parekh (Sterling Biotech Limited), Monisha Prabhu Macedo (Sterling Biotech Limited), Neha Champaben Prajapati (Sterling Biotech Limited), Priyadarshan Kumar Singh (Sterling Biotech Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available